FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386439136> ?p ?o ?g. }

• W4386439136 abstract "Sarcopenia is a poor prognostic factor in cancer patients, and exercise is one of the treatments to improve sarcopenia. However, there is currently insufficient evidence on whether exercise can improve sarcopenia in patients with advanced cancers. This study examined the feasibility of exercise in advanced gastrointestinal (GI) cancer patients treated with palliative chemotherapy.Between 2020 and 2021, 30 patients were enrolled in a resistance and aerobic exercise program for six weeks. The exercise intervention program (EIP) consisted of low, moderate, and high intensity levels. Patients were asked to select the intensity level according to their ability. The primary endpoint was the feasibility of the EIP measured by compliance during the six weeks. A compliance of over 50% was considered acceptable. The secondary endpoints were changes in weight and muscle mass, safety, quality of life (QoL) and overall survival (OS).The median age of the study's participants was 60 (30-77). The total compliance to the EIP was 63.3% (19/30 patients). Sixteen (53.3%) patients had a compliance of over 80%. The attrition rate was 30.0% (9/30). The mean exercise time was 41.4 min, and the aerobic exercise was 92.3% and the resistant exercise was 73.7%, and both exercise was 66.5%. Most patients performed the moderate intensity level exercises at home or near their home. The mean skeletal muscle index (SMI) was 43.5 cm2/m2 pre-chemotherapy and 42.2 cm2/m2 after six weeks of chemotherapy, with a decrease of -1.2 ± 2.8 cm2/m2 (-3.0%) (p = 0.030). In the poor compliance group, the mean SMI decrease was -2.8 ± 3.0 cm2/m2 which was significantly different (p = 0.033); however, in the good compliance group, the mean SMI decrease was -0.5 ± 2.5 cm2/m2 which was maintained over the six weeks (p = 0.337). The good compliance group had a significantly longer median OS compared with the poor compliance group (25.3 months vs. 7.9 months, HR = 0.306, 95% CI = 0.120-0.784, p = 0.014). The QoL showed a better score for insomnia (p = 0.042). There were no serious adverse events.The EIP during palliative chemotherapy in advanced GI cancer patients showed good compliance. In the good compliance group, muscle mass and physical functions were maintained for six weeks. The EIP was safe, and the QoL was maintained. Based on this study, further research in exercise intervention in advanced cancer patients is needed.The clinical trial registration number is KCT 0005615 (CRIS, https://cris.nih.go.kr/cris/en/ ); registration date, 23rd Nov 2020." @default.
• W4386439136 created "2023-09-06" @default.
• W4386439136 creator A5022487450 @default.
• W4386439136 creator A5022961974 @default.
• W4386439136 creator A5024408158 @default.
• W4386439136 creator A5053352888 @default.
• W4386439136 creator A5066690925 @default.
• W4386439136 creator A5072799823 @default.
• W4386439136 creator A5091808753 @default.
• W4386439136 date "2023-09-05" @default.
• W4386439136 modified "2023-10-18" @default.
• W4386439136 title "Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study" @default.
• W4386439136 cites W1967844817 @default.
• W4386439136 cites W1992514303 @default.
• W4386439136 cites W2097501147 @default.
• W4386439136 cites W2118558111 @default.
• W4386439136 cites W2196362857 @default.
• W4386439136 cites W2254075657 @default.
• W4386439136 cites W2275733417 @default.
• W4386439136 cites W2626721982 @default.
• W4386439136 cites W2888575486 @default.
• W4386439136 cites W2897698573 @default.
• W4386439136 cites W2903254661 @default.
• W4386439136 cites W3093230061 @default.
• W4386439136 doi "https://doi.org/10.1007/s00520-023-08017-6" @default.
• W4386439136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37668738" @default.
• W4386439136 hasPublicationYear "2023" @default.
• W4386439136 type Work @default.
• W4386439136 citedByCount "0" @default.
• W4386439136 crossrefType "journal-article" @default.
• W4386439136 hasAuthorship W4386439136A5022487450 @default.
• W4386439136 hasAuthorship W4386439136A5022961974 @default.
• W4386439136 hasAuthorship W4386439136A5024408158 @default.
• W4386439136 hasAuthorship W4386439136A5053352888 @default.
• W4386439136 hasAuthorship W4386439136A5066690925 @default.
• W4386439136 hasAuthorship W4386439136A5072799823 @default.
• W4386439136 hasAuthorship W4386439136A5091808753 @default.
• W4386439136 hasBestOaLocation W43864391361 @default.
• W4386439136 hasConcept C103038586 @default.
• W4386439136 hasConcept C121608353 @default.
• W4386439136 hasConcept C126322002 @default.
• W4386439136 hasConcept C159110408 @default.
• W4386439136 hasConcept C1862650 @default.
• W4386439136 hasConcept C203092338 @default.
• W4386439136 hasConcept C2776214593 @default.
• W4386439136 hasConcept C2776694085 @default.
• W4386439136 hasConcept C2779951463 @default.
• W4386439136 hasConcept C535046627 @default.
• W4386439136 hasConcept C71924100 @default.
• W4386439136 hasConceptScore W4386439136C103038586 @default.
• W4386439136 hasConceptScore W4386439136C121608353 @default.
• W4386439136 hasConceptScore W4386439136C126322002 @default.
• W4386439136 hasConceptScore W4386439136C159110408 @default.
• W4386439136 hasConceptScore W4386439136C1862650 @default.
• W4386439136 hasConceptScore W4386439136C203092338 @default.
• W4386439136 hasConceptScore W4386439136C2776214593 @default.
• W4386439136 hasConceptScore W4386439136C2776694085 @default.
• W4386439136 hasConceptScore W4386439136C2779951463 @default.
• W4386439136 hasConceptScore W4386439136C535046627 @default.
• W4386439136 hasConceptScore W4386439136C71924100 @default.
• W4386439136 hasIssue "10" @default.
• W4386439136 hasLocation W43864391361 @default.
• W4386439136 hasLocation W43864391362 @default.
• W4386439136 hasOpenAccess W4386439136 @default.
• W4386439136 hasPrimaryLocation W43864391361 @default.
• W4386439136 hasRelatedWork W1987413475 @default.
• W4386439136 hasRelatedWork W2008054780 @default.
• W4386439136 hasRelatedWork W2514733910 @default.
• W4386439136 hasRelatedWork W2898081386 @default.
• W4386439136 hasRelatedWork W3127173649 @default.
• W4386439136 hasRelatedWork W3134134177 @default.
• W4386439136 hasRelatedWork W3149563891 @default.
• W4386439136 hasRelatedWork W4366975589 @default.
• W4386439136 hasRelatedWork W4379526598 @default.
• W4386439136 hasRelatedWork W4382117200 @default.
• W4386439136 hasVolume "31" @default.
• W4386439136 isParatext "false" @default.
• W4386439136 isRetracted "false" @default.
• W4386439136 workType "article" @default.